Literature DB >> 15170929

Hypertension was the major risk factor leading to development of cardiovascular diseases among men with hyperuricemia.

Kuan-Chia Lin1, Hsuan-Ming Tsao, Chen-Huan Chen, Pesus Chou.   

Abstract

OBJECTIVE: A 7-year followup study among men with hyperuricemia was conducted to study the longterm relationships between serum uric acid concentrations and cardiovascular diseases. Any interaction between uric acid levels and other risk factors (e.g., obesity, hypertension) on the development of cardiovascular diseases was also examined.
METHODS: A total of 391 men with hyperuricemia aged 30 and over screened from the community-based Kinmen study in 1991-92 (the baseline study) were followed in 1997-98, with a 75% followup rate. Demographic, clinical, and biochemical data were collected in both baseline and followup periods.
RESULTS: After followup for 7 years, the significant risk factors of coronary heart disease were age, increase of uric acid level at followup, baseline systolic blood pressure, and increase of systolic blood pressure at followup. Factors independently associated with left ventricular hypertrophy included baseline systolic blood pressure and increase of systolic blood pressure at followup. Gouty syndrome, age, baseline fasting plasma glucose level, and increase of systolic blood pressure followup were significantly related to cardiac arrhythmia. After adjusting for baseline serum uric acid level, we found that hyperuricemic men with hypertension, especially overt hypertension stage 2 and stage 3, would predict cardiovascular disease incidence synergistically with uric acid level.
CONCLUSION: There is a positive and statistically significant relationship between gout and subsequent cardiac arrhythmia. Moreover, hypertension was the major risk factor leading to aggravation of development of atherosclerosis among hyperuricemic subjects. Gout and elevated uric acid level seemed not to be an independent risk factor for most cardiovascular diseases. Nevertheless, blood pressure level was predictive for cardiovascular disease incidence synergistically with serum uric acid level.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15170929

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  8 in total

1.  Change in serum uric acid between baseline and 1-year follow-up and its associated factors in male subjects.

Authors:  Jung-Yoon Choe; Sung-Hoon Park; Ji-Young Kim; Im-Hee Shin; Seong-Kyu Kim
Journal:  Clin Rheumatol       Date:  2007-09-14       Impact factor: 2.980

2.  Short-term effects of particulate matter exposure on emergency room visits for cardiovascular disease in Lanzhou, China: a time series analysis.

Authors:  Rui Chen; Qian Gao; Jianyun Sun; Haixia Yang; Yongjun Li; Fenyan Kang; Wei Wu
Journal:  Environ Sci Pollut Res Int       Date:  2020-01-08       Impact factor: 4.223

Review 3.  EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT).

Authors:  W Zhang; M Doherty; T Bardin; E Pascual; V Barskova; P Conaghan; J Gerster; J Jacobs; B Leeb; F Lioté; G McCarthy; P Netter; G Nuki; F Perez-Ruiz; A Pignone; J Pimentão; L Punzi; E Roddy; T Uhlig; I Zimmermann-Gòrska
Journal:  Ann Rheum Dis       Date:  2006-05-17       Impact factor: 19.103

4.  Association of white blood cell counts with left ventricular mass index in hypertensive patients undergoing anti-hypertensive drug therapy.

Authors:  Hongtao Shi; Hongxia Chu; Zhiyang Lv; Guanming Qi; Junjie Guo; Wei Fu; Xiaojing Wang; Xiangyu Guo; Junbo Ge; Chengqian Yin
Journal:  Exp Ther Med       Date:  2017-02-10       Impact factor: 2.447

5.  Uric acid: A new look at an old risk marker for cardiovascular disease, metabolic syndrome, and type 2 diabetes mellitus: The urate redox shuttle.

Authors:  Melvin R Hayden; Suresh C Tyagi
Journal:  Nutr Metab (Lond)       Date:  2004-10-19       Impact factor: 4.169

6.  Serum uric acid and low-density lipoprotein cholesterol levels are independent predictors of coronary artery disease in Asian Indian patients with type 2 diabetes mellitus.

Authors:  C A Jayashankar; Henley Punnen Andrews; Venkata BharatKumar Pinnelli; Basappaji Shashidharan; H N Nithin Kumar; Swaapnika Vemulapalli
Journal:  J Nat Sci Biol Med       Date:  2016 Jul-Dec

7.  Diagnosis and treatment for hyperuricaemia and gout: a protocol for a systematic review of clinical practice guidelines and consensus statements.

Authors:  Qianrui Li; Xiaodan Li; Joey Sum-Wing Kwong; Hao Chen; Xin Sun; Haoming Tian; Sheyu Li
Journal:  BMJ Open       Date:  2017-06-23       Impact factor: 2.692

8.  Relationships between Serum Uric Acid, Malondialdehyde Levels, and Carotid Intima-Media Thickness in the Patients with Metabolic Syndrome.

Authors:  Shun-Sheng Wu; Chew-Teng Kor; Ting-Yu Chen; Ko-Hung Liu; Kai-Lun Shih; Wei-Wen Su; Hung-Ming Wu
Journal:  Oxid Med Cell Longev       Date:  2019-10-09       Impact factor: 6.543

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.